eupolicy.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
This Mastodon server is a friendly and respectful discussion space for people working in areas related to EU policy. When you request to create an account, please tell us something about you.

Server stats:

210
active users

#cancerresearch

3 posts3 participants0 posts today

alojapan.com/1314235/comparabl Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net #AcuteMyeloidLeukaemia #Biomedicine #CancerResearch #general #Hematology #Hokkaido #HokkaidoNews #news #oncology #RiskFactors #北海道 Acute myeloid leukemia (AML) has a median age at diagnosis of 68 years, and many patients are deemed ineligible for…

Yesterday despite the infernal heat I managed to complete the medium course of the Gran Fondo del Mugello. Next year I will definitely repeat both the race and the fundraiser, trying to improve my time of 4 hours and 59 minutes on the medium or even attempt the long course. Many more heartfelt thanks to all the generous donors who supported me in this experience.

#cycling #cancerresearch #beatcancer #mugello #tuscany #fundraising

fundraise.cancerresearchuk.org

📢 Save the date! Our next IRIS Insights is coming up this Thursday, June 26 at 2:00 PM (CEST).

We’re delighted to welcome Prof. Monilola Olayioye, who will speak on:
🎙️ "Tumors in Dishes: New Opportunities for Personalized Medicine"

In her talk, Prof. Olayioye will explore how patient-derived tissue samples can be used to advance cancer treatment. She’ll share insights from the 3R-US team on developing human tumor models – often called “tumors in dishes” – and how they are applied in the lab to test new therapies. The talk will also highlight approaches like bioprinting, alternatives to animal testing, and cancer biotherapeutics designed to activate the immune system.

🎯 The goal: more personalized and more effective cancer therapies.

This is the third talk in our IRIS Insights series, which showcases interdisciplinary research from the IRIS community and provides a space for dialogue across fields.

🗓️ Thursday, 26 June
🕑 2:00 PM (CEST)
🔗 Join via Webex – link in bio/comments
🗣️ Language: English

We’re looking forward to an inspiring session and hope to see you online!

#IRISInsights #CancerResearch #3R #PersonalizedMedicine #Bioprinting #TumorModels #ScienceCommunication #SRFIRIS #UnivStuttgart
#BiomedicalResearch #Immunotherapy #FutureOfMedicine #TranslationalResearch #HumanTissueModels #NoAnimalTesting #OpenScience
#LifeSciences #HealthInnovation #AcademicTalk #InterdisciplinaryResearch #MedicalInnovation #WomenInScience #ScienceEvent #UniversityResearch

IRIS Board of Directors
Prof. Dr. André Bächtiger
Prof. Dr. Reinhold Bauer
Prof. Dr. Sibylle Baumbach
Dr. Miriam K.
Prof. Dr. @ai Staab
Jun.-Prof. Dr. Maria Wirzberger